BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35213477)

  • 1. Cochlear Implantation in Neurofibromatosis Type 2: Experience From the UK Neurofibromatosis Type 2 Service.
    Smith ME; Edmiston R; Trudel M; Freeman S; Stapleton E; Axon P; Donnelly N; Tysome JR; Bance M; Obholzer R; Jiang D; Mackeith S; Ramsden J; O'Driscoll M; Mawman D; Buttimore J; Nunn T; Humphries J; Evans DG; Lloyd SKW;
    Otol Neurotol; 2022 Jun; 43(5):538-546. PubMed ID: 35213477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ipsilateral cochlear implantation after cochlear nerve preserving vestibular schwannoma surgery in patients with neurofibromatosis type 2.
    Lloyd SK; Glynn FJ; Rutherford SA; King AT; Mawman DJ; O'Driscoll MP; Evans DG; Ramsden RT; Freeman SR
    Otol Neurotol; 2014 Jan; 35(1):43-51. PubMed ID: 24335931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of cochlear implantation in patients with neurofibromatosis type 2.
    North HJ; Mawman D; O'Driscoll M; Freeman SR; Rutherford SA; King AT; Hammerbeck-Ward C; Evans DG; Lloyd SK
    Cochlear Implants Int; 2016 Jul; 17(4):172-177. PubMed ID: 27691934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cochlear implantation in patients with neurofibromatosis type 2: variables affecting auditory performance.
    Carlson ML; Breen JT; Driscoll CL; Link MJ; Neff BA; Gifford RH; Beatty CW
    Otol Neurotol; 2012 Jul; 33(5):853-62. PubMed ID: 22664900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Cochlear Implantation in Neurofibromatosis Type 2 Related Hearing Loss.
    Sobczak G; Marchant W; Misurelli S; Pyle GM; Gubbels S; Roche J
    Ann Otol Rhinol Laryngol; 2023 Mar; 132(3):284-293. PubMed ID: 35450430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cochlear Implant Outcomes between Patients with Sporadic and Neurofibromatosis Type 2-Associated Vestibular Schwannoma.
    Dornhoffer JR; Haller T; Lohse CM; Driscoll CLW; Neff BA; Saoji A; Link MJ; Carlson ML
    Otol Neurotol; 2023 Sep; 44(8):791-797. PubMed ID: 37464449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cochlear implants to treat deafness caused by vestibular schwannomas.
    Mukherjee P; Ramsden JD; Donnelly N; Axon P; Saeed S; Fagan P; Irving RM
    Otol Neurotol; 2013 Sep; 34(7):1291-8. PubMed ID: 23921933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing Speech Recognition Outcomes Between Cochlear Implants and Auditory Brainstem Implants in Patients With NF2-Related Schwannomatosis.
    Dornhoffer JR; Plitt AR; Lohse CM; Driscoll CLW; Neff BA; Saoji AA; Van Gompel JJ; Link MJ; Carlson ML
    Otol Neurotol; 2024 Jan; 45(1):29-35. PubMed ID: 37875011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma.
    Lustig LR; Yeagle J; Driscoll CL; Blevins N; Francis H; Niparko JK
    Otol Neurotol; 2006 Jun; 27(4):512-8. PubMed ID: 16791043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cochlear Implant Outcomes in Neurofibromatosis Type 2: Implications for Management.
    Deep NL; Patel EJ; Shapiro WH; Waltzman SB; Jethanamest D; McMenomey SO; Roland JT; Friedmann DR
    Otol Neurotol; 2021 Apr; 42(4):540-548. PubMed ID: 33351557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Auditory rehabilitation of patients with neurofibromatosis Type 2 by using cochlear implants.
    Roehm PC; Mallen-St Clair J; Jethanamest D; Golfinos JG; Shapiro W; Waltzman S; Roland JT
    J Neurosurg; 2011 Oct; 115(4):827-34. PubMed ID: 21761973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cochlear implantation and auditory brainstem implantation in neurofibromatosis type 2.
    Peng KA; Lorenz MB; Otto SR; Brackmann DE; Wilkinson EP
    Laryngoscope; 2018 Sep; 128(9):2163-2169. PubMed ID: 29573425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. English consensus protocol evaluating candidacy for auditory brainstem and cochlear implantation in neurofibromatosis type 2.
    Tysome JR; Axon PR; Donnelly NP; Evans DG; Ferner RE; O'Connor AF; Freeman SR; Gleeson M; Halliday D; Harris F; Jiang D; Kerr R; King A; Knight RD; Lloyd SK; Macfarlane R; Mannion R; Mawman D; O'Driscoll M; Parry A; Ramsden J; Ramsden R; Rutherford SA; Saeed SR; Thomas N; Vanat ZH
    Otol Neurotol; 2013 Dec; 34(9):1743-7. PubMed ID: 24136318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hearing Rehabilitation in Patients With Neurofibromatosis Type 2: The Quebec's Experience With Auditory Implants.
    Khneisser E; Bussieres R; Côté M; Philippon D; Fradet G; Côté M; Lessard N; Champagne PO; Trudel M
    Otol Neurotol; 2023 Sep; 44(8):e621-e627. PubMed ID: 37550875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of cochlear implantation on the management strategy of patients with neurofibromatosis type 2.
    Tan H; Jia H; Li Y; Zhang Z; Zhu W; Cai Y; Wang Z; Wu H
    Eur Arch Otorhinolaryngol; 2018 Nov; 275(11):2667-2674. PubMed ID: 30229456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical management of vestibular schwannomas and hearing rehabilitation in neurofibromatosis type 2.
    Tysome JR; Macfarlane R; Durie-Gair J; Donnelly N; Mannion R; Knight R; Harris F; Vanat ZH; Tam YC; Burton K; Hensiek A; Raymond FL; Moffat DA; Axon PR
    Otol Neurotol; 2012 Apr; 33(3):466-72. PubMed ID: 22334163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF2-Related Intravestibular Schwannomas: Long-Term Outcomes of Cochlear Implantation.
    Jia H; Nguyen Y; Hochet B; Smail M; Mosnier I; Wu H; Sterkers O; Kalamarides M; Bernardeschi D
    Otol Neurotol; 2020 Jan; 41(1):94-99. PubMed ID: 31634276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cochlear implantation in patients with vestibular schwannoma: a single United Kingdom center experience.
    Pai I; Dhar V; Kelleher C; Nunn T; Connor S; Jiang D; O'Connor AF
    Laryngoscope; 2013 Aug; 123(8):2019-23. PubMed ID: 23616085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ipsilateral Cochlear Implantation in the Presence of Observed and Irradiated Vestibular Schwannomas.
    Urban MJ; Moore DM; Kwarta K; Leonetti J; Rajasekhar R; Gluth MB; Wiet RM
    Ann Otol Rhinol Laryngol; 2020 Dec; 129(12):1229-1238. PubMed ID: 32551844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cochlear Implantation in Patients With Neurofibromatosis Type 2.
    Tolisano AM; Baumgart B; Whitson J; Kutz JW
    Otol Neurotol; 2019 Apr; 40(4):e381-e385. PubMed ID: 30870359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.